Introduction: Who Should Seek Diagnostic Testing

Many people with lung carcinoid tumors discover their condition unexpectedly. In fact, around one out of every four people with these tumors has no symptoms when they receive their diagnosis. Instead, doctors find the tumor during a chest X-ray or CT scan done for a completely different reason, such as checking for a respiratory infection or investigating unrelated chest complaints.^[1][3]

However, some individuals experience warning signs that should prompt them to seek medical attention. If you develop a persistent cough that doesn’t go away, especially one that produces blood or thick mucus, this warrants a visit to your doctor. Similarly, recurring bouts of what seems like pneumonia, wheezing that develops without a clear cause, chest pain, or breathing difficulties that worsen over time are all reasons to undergo diagnostic testing. These symptoms occur because the tumor may be blocking an airway in your lung, preventing proper air flow and creating conditions where infections can take hold.^[1][4]

Less commonly, people notice symptoms related to hormones that the tumor produces. If a carcinoid tumor makes excessive amounts of the hormone serotonin (a chemical that helps regulate many body functions), you might experience severe diarrhea, sudden redness or warmth spreading across your face and neck, unexpected weight gain, or asthma-like breathing problems. This collection of symptoms is called carcinoid syndrome, and while it’s uncommon with lung carcinoid tumors compared to those in the digestive system, it does happen, particularly when tumors are very large or have already spread to other organs.^[1][4][5]

Classic Diagnostic Methods

Imaging Tests

The first step in identifying a possible lung carcinoid tumor usually involves looking inside your chest using various imaging technologies. A standard chest X-ray is often where the journey begins. This simple, quick test uses radiation to create pictures of your lungs and can reveal abnormal masses or areas that don’t look right. However, not all lung carcinoid tumors show up clearly on regular X-rays, especially if they’re very small or located in areas that are hard to see with this type of imaging.^[13][17]

When doctors need more detailed information, they turn to a computed tomography scan, commonly known as a CT scan. This test uses X-rays taken from multiple angles and combines them with computer processing to create cross-sectional images of your lungs, almost like looking at slices of bread in a loaf. A CT scan provides much clearer pictures than a standard X-ray and can show the size, shape, and exact location of a tumor. It can also reveal whether the tumor has spread to nearby lymph nodes or other organs, such as the liver, which is important information for planning treatment.^[1][13][17]

Another imaging option is magnetic resonance imaging, or MRI. Unlike CT scans that use X-rays, MRI uses powerful magnets and radio waves to create detailed pictures of your body’s soft tissues. Doctors may order an MRI to get additional information about how a tumor relates to nearby structures in your chest, particularly blood vessels and other soft tissues that might be harder to see clearly on a CT scan.^[13][17]

Nuclear medicine scans, including specialized tests called PET scans, involve injecting a small amount of radioactive material into your bloodstream. Cancer cells tend to absorb more of this substance than normal cells, causing them to light up on the scan. These tests are particularly helpful for determining whether a lung carcinoid tumor has spread to distant parts of your body. There are also specific types of nuclear scans designed for neuroendocrine tumors that can be especially useful because they target the unique characteristics of these cells.^[13][17]

Procedures to Look Inside Your Airways

Sometimes imaging tests show something suspicious, but doctors need to actually see the tumor directly and take a sample to confirm what it is. This is where procedures using scopes come in. A bronchoscopy involves passing a thin, flexible tube with a tiny camera on the end down your throat and into your lungs. The doctor can see the inside of your airways on a video screen and look for tumors. Lung carcinoid tumors found in the larger airways often appear as soft, pinkish or purplish masses covered with normal-looking airway lining. Because these tumors have a rich blood supply, they may bleed easily, which is why some people cough up blood.^[5][13][17]

During a bronchoscopy, the doctor can use special tools passed through the scope to take a small tissue sample, a procedure called a biopsy. This tissue is then sent to a laboratory where specialists examine it under a microscope to determine exactly what type of tumor is present. Getting this tissue sample is crucial because it allows doctors to distinguish lung carcinoid tumors from other types of lung cancer and to determine whether you have a typical or atypical carcinoid, which affects treatment planning.^[13][17]

For tumors located near the edges of the lungs, where bronchoscopy can’t easily reach, doctors might use a different approach. They may perform a needle biopsy, where a thin needle is inserted through the skin of your chest and into the tumor, guided by CT scan images. Another option for peripheral tumors is to collect tissue during surgery, especially if the tumor needs to be removed anyway. The type of biopsy performed depends on where the tumor is located and what approach will provide the most information with the least risk.^[13][17]

Blood and Urine Tests

Because carcinoid tumors can release hormones and other chemical substances, testing your blood and urine can provide valuable diagnostic clues. If you have a carcinoid tumor producing large amounts of hormones, your blood may contain higher than normal levels of these substances or the byproducts created when your body breaks them down. Similarly, your urine may show elevated levels of certain chemicals that result from hormone breakdown. These tests are particularly useful when doctors suspect carcinoid syndrome or when they want to monitor whether a tumor is producing hormones that could cause symptoms.^[7][13][17]

However, it’s important to understand that normal blood and urine test results don’t rule out lung carcinoid tumors. Many of these tumors, especially typical carcinoids confined to the lung, don’t produce enough hormones to show up in these tests. The tests are more helpful when positive than when negative, serving to confirm suspicions rather than to screen for the disease in the first place.^[5]

Examining the Tissue Under a Microscope

Once doctors obtain a tissue sample through biopsy, the real detective work begins in the pathology laboratory. Under a microscope, specialists examine the cells to determine their type and behavior. Lung carcinoid tumors belong to a family of cancers called neuroendocrine tumors, which start in special cells that have characteristics of both nerve cells and hormone-producing cells.^[1][3]

The pathologist’s job is to distinguish between typical carcinoid tumors and atypical carcinoid tumors. This distinction is crucial because these two types behave quite differently. Typical carcinoids grow very slowly and rarely spread to other parts of the body. Under the microscope, they show organized patterns with very few cells actively dividing. Atypical carcinoids, on the other hand, grow faster, are more likely to spread to distant organs, and show different patterns when examined microscopically, including more cell division and areas where cells have died.^[1][3][7]

To help confirm the diagnosis and distinguish carcinoid tumors from other types of lung cancer, pathologists often perform additional tests on the tissue called immunohistochemistry. These tests use special stains that react with specific proteins found in neuroendocrine cells. If the tissue lights up with these stains in characteristic patterns, it confirms that the tumor is indeed a neuroendocrine tumor and helps classify it more precisely.^[14]

Diagnostics for Clinical Trial Qualification

If you’re considering participating in a clinical trial to access new treatments for lung carcinoid tumors, you’ll likely need to undergo a comprehensive set of diagnostic tests. Clinical trials have strict entry criteria to ensure that the experimental treatment is tested in the right group of patients and that researchers can accurately measure its effects.^[3]

First and foremost, clinical trials require confirmed histologic diagnosis, meaning that tissue samples examined under a microscope have definitively shown that you have a lung carcinoid tumor and specified whether it’s typical or atypical. This confirmation can’t come from imaging tests alone; it must come from actual tissue analysis. Trials may also require specific immunohistochemistry results showing that your tumor cells have certain protein markers characteristic of neuroendocrine tumors.^[14]

Clinical trials almost always require detailed imaging to determine the stage of your cancer, which describes how large the tumor is and whether it has spread. This staging process typically involves CT scans of your chest and abdomen, and often PET scans or specialized nuclear medicine scans. Knowing the exact stage of your disease helps researchers understand whether you’re a candidate for trials testing treatments for localized disease versus those evaluating therapies for cancer that has spread to other organs.^[3][10]

Many trials test treatments that work by targeting specific molecular features of cancer cells. To qualify for these studies, you may need molecular testing on your tumor tissue to determine whether it has the genetic or protein characteristics that the experimental drug is designed to target. This testing looks for specific mutations, gene expressions, or protein levels that might predict whether the treatment will work for your particular tumor.^[3]

Clinical trials also assess your overall health to ensure you’re strong enough to tolerate the experimental treatment and to establish baseline measurements against which to compare your progress. This assessment typically includes standard blood tests checking your liver function, kidney function, and blood cell counts. These tests help determine whether your organs can safely process and eliminate the study drug and whether your body has adequate reserves to handle potential side effects.^[3]

You may also need tests of your heart and lung function. An electrocardiogram (ECG) checks your heart’s electrical activity, and sometimes an echocardiogram uses ultrasound to evaluate how well your heart pumps. Since lung carcinoid tumors affect your respiratory system, pulmonary function tests measure how well your lungs work by having you breathe into special devices that assess your lung capacity and air flow. These baseline measurements are important because they help researchers understand whether the treatment affects these vital functions.^[20]

For trials involving patients with carcinoid syndrome, you may need specific blood and urine tests measuring hormone levels or their breakdown products. These measurements help confirm that you have the hormone-related symptoms that the treatment aims to control and provide baseline values to track whether the therapy reduces hormone production.^[3]

Clinical trial protocols often require that all diagnostic testing be current, typically within a specific timeframe before you can enroll, such as within four weeks. This ensures that the information accurately reflects your current condition. Some trials may also require that tissue samples or imaging be reviewed by the study’s central pathology or radiology laboratory to ensure consistent interpretation across all participating research sites.^[3]